The phase 2a trial showed GR-0621 met primary and secondary endpoints, demonstrating safety and efficacy over 12 weeks. Phase 2a data show oral GRI-0621 was safe and improved immune and fibrosis ...

Activation of immune blood biomarkers from interferon gamma pathway distinguished long term survivors (>=2 years) from ...

HPV status, particularly combined p16 and HPV positivity, is vital for patient selection in de-escalation strategies for ...

A new blood marker reflects the extent of brain injury after an ischemic stroke and can predict patient outcomes months to ...

Enrique Velazquez Villarreal, MD, PhD, MPH, MS, reveals how AI is being used to identify early-onset CRC and enhance ...

(RTTNews) - Cognition Therapeutics Inc. (CGTX), a clinical-stage biopharmaceutical company, on Monday, provided an update on a biomarker analysis from its phase II SHINE study of CT1812in ...

New exploratory findings demonstrate that in responders with IGFBP7 biomarker decline, CNM-Au8 30mg was strongly associated ...

Combining a host biomarker with large language model analysis improves lower respiratory tract infection diagnosis in ICU ...

The Translational Research Institute for Space Health (TRISH) at Baylor College of Medicine’s Center for Space Medicine, with consortium partners California Institute of Technology and Massachusetts ...

This cross-sectional study of 191 adolescent girls found that ≥2 hours of organized recreational physical activity in the ...

According to MarketsandMarkets™, the Predictive Clinical Biomarkers Market is projected to grow from about USD 8.49 billion ...